Abstract
Probiotics are described as “friendly bacteria” that could improve the intestine defense by interacting with the resident microflora. There is a large body of evidence suggesting that consumption of functional food containing probiotics exerts positive effects on human health. Several clinical trials have highlighted the efficiency of probiotics in the prevention and treatment of different gastrointestinal disorders including the prevention of antibiotic associated diarrhea, the remission in patients with inflammatory bowel disease, beneficial effects against Helicobacter pylori infection, positive effects in patients affected by allergies and atopic diseases. The clinical benefits of probiotics use are mainly attributed to their antimicrobial substances production and their positive interactions with the enterocytes to reinforce the intestinal epithelial barrier. Moreover, there is evidence suggesting that probiotics stimulate both specific and non-specific host immune responses. Recently, have been published some experiments performed with the DNA microarray technology which provided a global gene screening of the complex bacteria-host interplay. Nevertheless, the molecular mechanisms by which probiotics enhance the intestinal host defense are still not completely elucidated. Here, we review the experiments and clinical studies to date on the complex mechanisms regulating the communication between probiotics and their hosts.
Similar content being viewed by others
References
Arunachalam, K., Gill, HS., Chandra, RK. (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis.European Journal Clinical Nutrition 54; 1–5.
Bernet, ME., Brassart, D., Neeser, JR., Servin, AL. (1994) Lactobciluus acidophilus LA1 binds to culture human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.Gut 35; 483–89.
Bibiloni, R., Fedorak, RN., Tannock, GW., Madsen, KL., Gionchetti, P., Campirei, M., De Simone, C., Sartor, RB. (2005) VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis.American Journal of gastroenterology 100; 1539–46.
Braat, H., Van den Brande, J., Van Tol, E., Hommes, D., Peppelenbosch, M., Van Deventer, S. (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function.American Journal of Clinical Nutrition 80; 1618–25.
Chauviere, G., Coconnier, MH., Kerneis, S., Fourniat, J., Servin, AL. (1992) Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells.Journal of General Microbiology 138; 1689–96.
Ciprandi, G., Vizzaccaro, A., Cirillo, I., Tosca, M.A. (2005) Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study.Allergie et Immunologie 37; 129–34.
Collado, MC., Hernandez, M., Sanz, Y. (2005) Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains.Journal of Food Protection 68; 1034–40.
Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, E.C., Lupascu, A., Gasbarrini, G., Gasbarrini, A. (2002a) Probiotics in antibiotic-associated diarrhea.Digestive and Liver Disease 34, S78–80.
Cremonini, E, DiCaro, S., Covino, M., Armuzzi, A., Gabrielli, M., Santarelli, L., Nista, EC., Cammarota, G., Gasbarrini, G., Gasbarrini, A. (2002b) Effect of different probiotic preparations on anti-helicobacter pilori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.American Journal of Gastroenterology 97, 2744–9.
Di Caro, S., Tao, H., Grillo, A., Elia, C., Gasbarrini, G., Sepulveda, AR., Gasbarrini, A. (2005a) Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa.Digestive and Liver Disease 37; 320–9.
Di Caro, S., Tao, H., Grillo, A., Franceschi, F., Elia, C., Zocco, MA., Gasbarrini, G., Sepulveda, A., Gasbarrini, A. (2005b) Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis.European Journal of Gastroenterology and Hepatology 17; 951–60.
Fang, W., Shi, M., Huang, L., Chen, J., Wang, Y. (1996) Antagonism of lactic acid bacteria towards Staphylococcus aureus and Escherichia coli on agar plate and in milk.Veterinary Research 27; 3–12.
Gill, HS., Rutherfurd, KJ., Cross ML. (2001a) Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes.Journal of Clinical Immunology 21; 264–71.
Gill, HS., Rutherfurd, KJ. (2001b) Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice.The British Journal of Nutrition 86; 285–9.
Gionchetti, P., Rizzello, E, Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggiolo, G., Miglioli, M., Campieri, M. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.Gastroenterology 119; 305–9.
Hommes, D., van den Blink, B., Plasse, T., Bartelsman, J., Xu, C., Macpherson, B., Tytgat, G., Peppelenbosch, M., Van Deventer, S. (2002) Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn’s disease.Gastroenterology 122; 7–14.
Isolauri, E., Majamaa, H., Arvola, T., Rantala, I., Virtanen, E., Arvilommi, H. (1993) Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats.Gastroenterology 105; 1643–50.
Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.Lancet 357; 1076–9.
Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H., Isolauri, E. (2003) Probiotics and prevention of atopic disease: 4 year follow-up of a randomized placebo-controlled trial.Lancet 361; 1869–71.
Kim, HJ., Vazquez Roque MI., Canilleri, M., Stephens, D., Burton, DD., Baxter, K., Thomforde, G., Zinsmeister, AR. (2005) A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.Neurogastroenterology and Motility 17; 687–96.
Kimoto, H., Mizumachi, K., Okamoto, T., Kurisaki, J. (2004) New Lactococcus strain with immunomodulatory activity: enhancement of Thl-type immune response.Microbiology and Immunology 48; 75–82.
Kitazawa, H., Ino, T., Kawai, Y., Itoh, T., Saito, T. (2002) Anovel immunostimulating aspect of Lactobacillus gasseri: induction of “Gasserokine” as chemoattractants for macrophages.International Journal of Food Microbiology 77; 29–38.
Korhonen, R., Korpela, R., Moilanen, R. (2002) Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoicacid.Inflammation 26; 207–14.
Lammers, KM., Vergopoulos, A., Babel, N., Gionchetti, P., Rizzello, E, Morselli, C., Caramelli, E., Fiorentino, M., d’Erico, A., Volk, HD., Campieri, M. (2005) Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-lbeta, interleukin-8, and interferon-gamma gene expression.Inflammatory Bowel Diseases 11; 447–54.
Lee, Y. and Lee, TS. (2005) Enhancement in ex vivo phagocytic capacity of peritoneal leukocytes in mice by oral delivery of various lactic-acid-producing bacteria.Current Microbiology 50; 24–7.
Lin, HC., Su, BH., Chen, AC., Lin, TW., Tsai, CH., Yeh, TE., Oh, W. (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.Pediatrics 115; 1–4.
Mack, DR., Ahme, S., Hyde, L., Wei, S., Hollingsworth, MA. (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro.Gut 52; 827–33.
Madsen, K., Cornish, A., Soper, P., McKaigney C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., DeSimone, C. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function.Gastroenterology 121; 580–91.
Malin, M., Suomalainen, H., Saxelin, M., Isolauri, E. (1996) Promotion of IgA immune response in patients with Crohn’s disease by oral bacteriotherapy with Lactobacillus GG.Annals of Nutrition and Metabolism 40; 137–45.
Matsuzaki, T., Yamasaki, R., Hashimoto, S., Yokokura, T. (1998) The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice.Journal of Dairy Science 81(1); 48–53.
Mattar, AF., Teitelbaum, DH., Drongowski, RA., Yongyi, F., Harmon, CM., Coran, AG. (2002) Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model.Pediatric Surgery International 18; 586–90.
Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I.C., Nicholls, R.J., Giochetti, P., Campirei, M., Kamm, MA. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.Gut 53, 108–14.
Montalto, M., Maggiano, N., Ricci, R., Curigliano, V., Santoro, L., Di Nicuolo, F., Vecchio, FM., Gasbarrini, A., Gasbarrini, G. (2004) Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells.Digestion 69; 225–8.
Myllyluoma, E., Veicola, L., Ahlroos, T., Tynkkynen, S., Kankuri, E., Vapaatalo, H., Rautelin, H., Korpela, R. (2005) Probiotic supplementation improves tolerance to Helicobacter pilori eradication therapy a placebo-controlled, double-blind randomized pilot study.Alimentary Pharmacology & Therapeutics 21, 1263–72.
Nurmi, JT, Puolakkainen, PA., Rautonen, NE. (2005) Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-l and down-regulates Cox-2 gene expression in a Caco-2 cell culture model.Nutrition and Cancer 51; 83–92.
O’Neil D.A., Cole, SP., Martin-Porter, E., Housley, MP., Liu, L., Ganz, T., Kagnoff MF. (2000) Regulation of human beta defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1.Infection and Immunity 68; 5412–5.
Otte, JM. et Podolsky, DK. (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms.American Journal of Physiology, Gastrointestinal and Liver Physiology 286; G613–26.
Parra, MD., Martinez de Morentin, BE., Cobo, JM., Mateos, A., Martinez, JA. (2004) Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defence capacity in healthy middle-aged people,Journal of physiology and Biochemistry 60; 85–91.
Paton, AW., Jennings, MP., Morona, R., Wang, H., Focareta, A., Roddam, LF., Paton, JC. (2005) Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.Gastroenterology 128; 1509–12.
Pena, JA., Versalovic, J. (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independant mechanism.Cellular Microbiology 5; 277–85.
Perdigon, G., Alvarez, S., Rachid, M., Aguero, G., Gobbato, N. (1995) Immune system stimulation by probiotics.Journal of dairy science 78; 1597–606.
Pohjavuori, E., Viljanen, M., Korpela, R., Kuitunen, M., Tiittanen, M., Vaarala, O., Savilahti, E. (2004) Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy.The Journal of Allergy and Clinical Immunology 114; 131–6.
Powrie, F., Coffman, RL. (1993) Cytokine regulation of T-cell function: potential fortherapeutic intervention.Immunology Today 14; 270–4.
Rautava, S., Kalliomaki, M., Isolauri, E. (2002) Probiotics durino pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant.The Journal of Allergy and Clinical Immunology 109; 119–121.
Rodrigues, AC, Cara, DC., Fretez, SH., Cunha, FQ., Vieira, EC., Nicoli, JR., Vieira, LQ. (2000) Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice.Journal of Applied Microbiology 89; 404–14.
Shu, Q., Gill, HS. (2001) A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia Coli 0157: H7 infection in mice.Medical Microbiology and Immunology 189; 147–52.
Shu, Q., Gill, HS. (2002) Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia Coli 0157: H7 infection in mice. FEMSImmunology and Medical Microbiology 34; 59–64.
Smith, JM., Johanesen, PA., Wendt, MK., Binion, DG., Dwinell, MB. (2004) CXCL12 activation of CXCR4 regulates mucosal host defence through stimulation of epithelial cell migration and promotion of intestinal barrier integrity.American Journal of Physiology Gastrointestinal and Liver Physiology 288; G316–26.
Surawicz, CM., Elmer, GW., Speelman, P., McFarland, LV, Chinn, J., van Belle, G. (1989) Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: a prospective study.Gastroenterology 96; 981–88.
Sturm, A., Rilling, K., Baumgart, DC., Gargas, K., Abou-Ghazale, T., Raupach, B., Eckert, J., Schumann, R., Enders, C., Sonnenborn, U., Wiedenmann, B., Dignass, AU. (2005) Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expression via toll-like receptor 2 signaling.Infection and Immunity 73; 1452–65.
Tao, Y., Drabik, KA., Waypa, TS., Musch, MW., Alverdy, JC., Schneewind, O., Chang, EB., Petrof, EO. (2005) Soluble factors from the probiotic Lactobacillus GG activate MAP kinases and induce cytoprotective heat shock proteins in intestinal epithelial cells.American journal of Physiology, Cell Physiology Nov (Epub ahead of print).
Tuomola EM.; Salminen SJ. (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures.International Journal of Food Microbiology 41; 45–51.
Veckman, V., Miettinen, M., Matikainen, S., Lande, R., Giacomini, E., Coccia, EM., Julkunen, I. (2003)Journal of Leukocyte Biology 74; 395–402.
Viljanen, M., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., Kuitunen, M. (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.Allergy 60; 494–500.
Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., Schroder, J.M., Stange, E.F. (2004) NF-kappaB and AP-1 mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of probiotic bacterium.Infection and Immunity 72; 5750–8.
Weizman, Z., Asli, G., Alsheikh, A. (2005) Effect of aprobiotic infant formula on infections in child care centers: comparison of two probiotic agents.Pediatrics 115; 5–9.
Yan, F. & Brent Polk, D. (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.The Journal of Biological Chemistry 277; 50959–65.
Zhang, L., Li, N., Caicedo, R., Neu, J. (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis-factor induced in terleukin-8 in Caco-2 cells.Journal of Nutrition 135; 1752–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saulnier, N., Zocco, M.A., Di Caro, S. et al. Probiotics and small bowel mucosa: Molecular aspects of their interactions. Genes Nutr 1, 107–115 (2006). https://doi.org/10.1007/BF02829952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02829952